A world-first clinical trial launched in Melbourne is being hailed as a "game-changer" for its potential to revolutionize the ...

The answer to this inquiry is “yes” — but maybe “no.” Will confidentiality agreements shield any prior art concerns? Once ...

As the pharmaceutical industry continues to push the boundaries of innovation, the role of digital solutions like eCOA ...

Tresidder said his Melbourne-based firm has “a real focus” on biotech and life sciences. He sketched some of the ways brokers ...

The FDA’s decision to ban dyes and other synthetic substances often rests on the Delaney clause, a 49‑word law from 1958 that ...

In a dynamic environment, an expert shares insights into potential AI applications in the clinical research setting at OCT ...

Casemiro has had its trials and tribulations at Man Utd over the past two years but the Brazilian has enjoyed a renaissance ...

In 2025, newly-designed clinical trials for people with cancer are providing new options and hope for patients and their families, including in the D.C. area.

Despite these benefits, biosimilar medicines remain under-recognised and underused in many markets. Real-world uptake often ...

As the world begins to more heavily rely on artificial intelligence (AI), keeping people and their businesses in the know can ...

Despite a general agreement, state budget negotiations persist, with unresolved issues such as the school aid formula.

Senescent skin cells, often referred to as zombie cells because they have outlived their usefulness without ever quite dying, ...